Temporal decline in non–high-density lipoprotein cholesterol in subjects with diabetes mellitus without atherosclerotic cardiovascular disease
Open Access
- 1 July 2020
- journal article
- research article
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 14 (4) , 425-430
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Assessment of omega‐3 carboxylic acids in statin‐treated patients with high levels of triglycerides and low levels of high‐density lipoprotein cholesterol: Rationale and design of the STRENGTH trialClinical Cardiology, 2018
- An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemiaJournal of Clinical Lipidology, 2013
- Indices of Cholesterol Metabolism and Relative Responsiveness to Ezetimibe and SimvastatinThe Journal of Clinical Endocrinology & Metabolism, 2010
- Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysisThe Lancet, 2008
- Efficacy and Safety of Atorvastatin in the Prevention of Cardiovascular End Points in Subjects With Type 2 DiabetesDiabetes Care, 2006
- Effect of Lowering LDL Cholesterol Substantially Below Currently Recommended Levels in Patients With Coronary Heart Disease and DiabetesDiabetes Care, 2006
- Joint Distribution of Non-HDL and LDL Cholesterol and Coronary Heart Disease Risk Prediction Among Individuals With and Without DiabetesDiabetes Care, 2005
- Reduction in Cardiovascular Events With Atorvastatin in 2,532 Patients With Type 2 DiabetesDiabetes Care, 2005
- Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trialThe Lancet, 2004
- Diabetic Dyslipidemia: Causes and ConsequencesThe Journal of Clinical Endocrinology & Metabolism, 2001